摘要:
The present invention discloses novel methods and compositions for viral inhibition, particularly inhibition of HCV and SARS. The invention also provides compositions including novel oxoazepanylacetamide derivatives useful for viral inhibition.
摘要:
The present invention discloses methods and compositions for viral inhibition, particularly inhibition of HCV and SARS. The invention also provides compositions including carbazole derivatives useful for viral inhibition.
摘要:
A device management apparatus including a receiving unit configured to receive state information indicating a change in a state of a device and store the state information in a state information storage unit; a sending unit configured to send report information relating to the state information to a predetermined destination, when the state information received by the receiving unit corresponds to a report target; and a changing unit configured to expand the report targets when an operation state of the device does not fulfill a scheduled state of a present time point, the operation state being identified based on history of the state information stored in the state information storage unit.
摘要:
A first acquisition unit acquires an event notification from an MFP and updates first device-status information. A transmission unit transmits the event notification and first reference-destination information. A switching unit switches a first access to the first reference-destination information to a second access to second reference-destination information. A second acquisition unit issues an acquisition request at a first interval, issues an acquisition request at a second interval in response to the event notification, acquires the second device-status information, and update the first device-status information.
摘要:
An information processing apparatus is communicable with a device via a first communication channel and communicable with a device management apparatus for managing the device via a second communication channel. The information processing apparatus includes a request generator configured to generate a first device information acquisition request in a second protocol based on a device information acquisition request in a first protocol transmitted from the device management apparatus via the second communication channel; a first transmitter configured to transmit the first device information acquisition request to the device via the first communication channel; a first receiver configured to receive a first device information acquisition response in the second protocol including device information from the device via the first communication channel; and a response generator configured to generate a device information acquisition response in the first protocol based on the first device information acquisition response.
摘要:
An information processing apparatus is communicable with a device via a first communication channel and communicable with a device management apparatus for managing the device via a second communication channel. The information processing apparatus includes a request generator configured to generate a first device information acquisition request in a second protocol based on a device information acquisition request in a first protocol transmitted from the device management apparatus via the second communication channel; a first transmitter configured to transmit the first device information acquisition request to the device via the first communication channel; a first receiver configured to receive a first device information acquisition response in the second protocol including device information from the device via the first communication channel; and a response generator configured to generate a device information acquisition response in the first protocol based on the first device information acquisition response.
摘要:
The present invention relates to compounds that are useful for treating cellular proliferative diseases, for treating disorders mediated, at least in part, by KSP, and for inhibiting KSP. The invention also related to pharmaceutical compositions comprising such compounds, methods of treating cancer by the administration of such compositions, and processes for the preparation of the compounds. Compounds of the invention have the following formula:
摘要:
The present invention provides aminopyrimidine compounds of formula (I) and their salts, wherein R1, R2, R3, R4, R5, R6, Q, Z, L, m, n are defined as the description, the methods for preparation thereof, the uses thereof and the pharmaceutical compositions comprising the effective amount of compounds of formula (I). The compounds of formula (I) and their salts can be used as protein kinase inhibitors.
摘要:
The present invention relates to new substituted quinoline compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:
摘要:
Tetrahydrocarboline compounds, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the tetrahydrocarboline compounds, either alone or in combination with at least one additional therapeutic agent. Methods of using the tetrahydrocarboline compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases.